Date | Title | Description | Source |
30.08.2021 | Poseida Therapeutics Announces FDA Clearance of Investigatio... |
SAN DIEGO, Aug. 30, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-sta... | prnewswire... |
02.06.2021 | Poseida Therapeutics Announces Virtual 2021 Annual Meeting o... |
SAN DIEGO, June 2, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stag... | prnewswire... |
06.05.2021 | Poseida Therapeutics Announces Key Additions to Immuno-Oncol... |
SAN DIEGO, May 6, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage... | prnewswire... |
23.03.2021 | Poseida Therapeutics Announces Carl June, M.D., to Chair Imm... |
SAN DIEGO, March 23, 2021 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-st... | prnewswire... |
02.11.2020 | Poseida Therapeutics Announces Clinical Hold Lifted on Phase... |
SAN DIEGO, Nov. 2, 2020 /PRNewswire/ -- Poseida Therapeutics, Inc., (Nasdaq: PSTX), a clinical-sta... | prnewswire... |
21.10.2020 | Poseida Therapeutics and TScan Therapeutics Announce Researc... |
SAN DIEGO and WALTHAM, Mass., Oct. 21, 2020 /PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ:PST... | prnewswire... |
23.09.2020 | Healthcare VC Firm Longitude Capital Closes $585M Fund | What You Should Know:
– Healthcare venture capital firm Longitude Capital announces the close of it... | hitconsult... |
23.09.2020 | Longitude Capital Raises $585 Million Fund to Invest in Tran... | - Longitude Venture Partners IV will build on the Firm’s commitment to improve clinical outcomes, en... | marketscre... |
13.07.2020 |
Poseida Therapeutics Debuts In IPO
| San Diego-based biopharmaceuticals firm Poseida Therapeutics successfully made it to the public mark... | socaltech.... |
26.06.2020 | Poseida Therapeutics has closed a $110M Series D while it pr... | - | connect.or... |
25.06.2020 | Poseida Therapeutics Raises $110 Million in Series D Financi... | SAN DIEGO, June 25, 2020 — Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company de... | aislingcap... |
25.06.2020 | Poseida Therapeutics Raises $110M To Advance Gene Therapeuti... | 8 Shares Email Facebook Twitter LinkedIn
A year after closing its largest raise to date, biopharmac... | news.crunc... |
25.06.2020 | Poseida Therapeutics Raises $110M in Series D Financing | Poseida Therapeutics, Inc., a San Diego, CA-based clinical-stage biopharmaceutical company dedicated... | finsmes.co... |
25.06.2020 | Poseida Therapeutics Lands $110M Series D |
SAN DIEGO, CA, Poseida Therapeutics today announced the closing of a Series D financing round, rai... | vcnewsdail... |
25.06.2020 |
Poseida Therapeutics Finds $110M More
| San Diego-based biopharmaceuticals developer Poseida Therapeutics has raised $110M more in funding, ... | socaltech.... |
14.05.2019 | Poseida Therapeutics, Be The Match BioTherapies team up on C... | Poseida plans to start a Phase II study of P-BCMA-101, a CAR-T therapy that targets the antigen BCMA... | medcitynew... |
14.05.2019 | Takeda forecasts $1.7B loss after Shire integration; F... | → Takeda’s $TAK first set of financial results since consummating its $62 billion acquisi... | endpts.com... |
28.04.2019 | Poseida Therapeutics Raises $142M in Series C Round | Eric Ostertag Poseida CEO
Poseida Therapeutics raised $142 million in a Series C round to advance t... | sdbj.com/n... |
22.04.2019 | Poseida Therapeutics Snares $142M in Series C |
SAN DIEGO, CA, Clinical-stage biopharmaceutical company has raised $142 million in Series C.
>... | vcnewsdail... |
22.04.2019 | Poseida Therapeutics Closes $142M Series C Financing | Poseida Therapeutics Inc., a San Diego, CA-based clinical-stage biopharmaceutical company leveraging... | finsmes.co... |
22.04.2019 | Poseida raises $142M in Series C round to advance multiple m... | The company’s lead product candidate is P-BCMA-101, an autologous CAR-T that targets the BCMA antige... | medcitynew... |
22.04.2019 | Vaping Startup Pax Labs Raises $420 Million in Funding: Term... | A UNICORN THAT VAPES
We’ve got another vaping unicorn.
Paid Content You can't secure what you can'... | fortune.co... |
22.04.2019 | CAR-T maker Poseida forgoes IPO, hauls in $142M series C ins... | CAR-T developer Poseida Therapeutics has put the kibosh on its IPO plans for now and is settling ins... | fiercebiot... |
22.04.2019 | Poseida Therapeutics Raises $142 Million In Series C Financi... | SAN DIEGO, April 22, 2019 — Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company le... | aislingcap... |
22.04.2019 |
Poseida Therapeutics Finds $142M
| San Diego-based Poseida Therapeutics, a biopharmaceuticals startup developing non-viral gene enginee... | socaltech.... |
22.04.2019 | CAR-T maker Poseida forgoes IPO, hauls in $142M series C ins... | CAR-T developer Poseida Therapeutics has put the kibosh on its IPO plans for now and is settling ins... | fiercebiot... |
10.04.2018 | Poseida Therapeutics Raises $30.5M to Further Develop Cancer... | Poseida Therapeutics Inc., a San Diego-based biotechnology company using gene editing to develop med... | sdbj.com/n... |
05.04.2018 | Poseida Therapeutics Hauls in $30.5M Series B |
SAN DIEGO, CA, Poseida Therapeutics has raised $30.5 million in an oversubscribed Series B financi... | vcnewsdail... |
05.04.2018 | Term Sheet — Thursday April 5 | GOT MONEY
Good morning, Term Sheet readers.
Paid Content How can you protect what you can't see? F... | fortune.co... |
03.04.2018 | Poseida Raises $30.5M in Series B Financing | Poseida Therapeutics, Inc., a San Diego-based company translating gene engineering technologies into... | finsmes.co... |
29.12.2015 | Daily funding roundup - December 29, 2015 | Poseida Therapeutics secured $23M; Bellhops, Inc raised $13.5M; PastBook received $380k financing
P... | vator.tv/n... |
20.12.2015 | Poseida Therapeutics Closes Series A Financing | Poseida Therapeutics, Inc., a La Jolla, CA-based human therapeutics company, closed a Series A finan... | finsmes.co... |
- | Poseida Therapeutics, Be The Match BioTherapies team up on C... | A company developing CAR-T therapies for multiple myeloma and prostate cancer is teaming up with a f... | medcitynew... |
- | Poseida raises $142M in Series C round to advance multiple m... | A Swiss drugmaker that markets one of the two approved CAR-T cell therapies has led the latest finan... | medcitynew... |